Please login to the form below

Not currently logged in

Quanticate expands and relocates to Research Triangle

CRO moves to North Carolina after partnership-driven growth

Research Triangle Region north carolina

A growth in the number of its functional support partnerships in areas such as biostatistics and statistical programming has prompted Quanticate to relocate to North Carolina's Research Triangle.

The global clinical research organisation (CRO) will move its US office from Boston to Research Triangle, already home to a number of biotech and life science companies.

Daniel Chapple, Quanticate's chief commercial officer, said: "Due to a number of large-scale partnerships being awarded to Quanticate, we saw the need to expand our US presence and relocate our US headquarters to the Research Triangle in North Carolina.

“This move provides us with the opportunity of operating within a scalable and growing business region dedicated to the life science industry.”

The move is part of a larger global initiative at the CRO that is aimed at continuing growth in its programming, statistics, medical writing, data management and pharmacovigilance operations.

Jointly headquarters in the UK and the US, Quanticate will open its new North Carolina office in the third quarter of this year.

21st June 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...